Filtered By:
Condition: Atrial Fibrillation
Countries: USA Health

This page shows you your search results in order of date. This is page number 16.

Order by Relevance | Date

Total 257 results found since Jan 2013.

Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States.
Conclusions -Among ESKD patients with AF on dialysis, apixaban use may be associated with lower risk of major bleeding compared with warfarin, with a standard 5 mg twice a day dose also associated with reductions in thromboembolic and mortality risk. PMID: 29954737 [PubMed - as supplied by publisher]
Source: Circulation - June 28, 2018 Category: Cardiology Authors: Siontis KC, Zhang X, Eckard A, Bhave N, Schaubel DE, He K, Tilea A, Stack AG, Balkrishnan R, Yao X, Noseworthy PA, Shah ND, Saran R, Nallamothu BK Tags: Circulation Source Type: research

Stroke Prevention for High-Risk Atrial Fibrillation in the Emergency Setting: Differences Between Canada and the United States
Publication date: July 2018 Source:Canadian Journal of Cardiology, Volume 34, Issue 7 Author(s): Bory Kea, Benjamin C. Sun, David R. Vinson
Source: Canadian Journal of Cardiology - June 27, 2018 Category: Cardiology Source Type: research

Postapproval Community Hospital Experience in the United States with Left Atrial Appendage Closure Device (Watchman)
To review the procedural safety and postimplantation complications of Watchman device implanted at 2 community hospitals for primary prevention of systemic embolization in patients with nonvalvular atrial fibrillation (NVAF) who were not candidates for long-term oral anticoagulation (OAC).
Source: Journal of Stroke and Cerebrovascular Diseases - May 29, 2018 Category: Neurology Authors: Koroush Khalighi, Munish Sharma, Rohit Masih, Vadim Levin Source Type: research

Stroke ‐prevention strategies in North American patients with atrial fibrillation: The GLORIA‐AF registry program
Clinical Cardiology, EarlyView.
Source: Clinical Cardiology - May 10, 2018 Category: Cardiology Authors: William F. McIntyre , David Conen , Brian Olshansky , Jonathan L. Halperin , Emil Hayek , Menno V. Huisman , Gregory Y.H. Lip , Shihai Lu , Jeff S. Healey Source Type: research

A Review of the Use of Direct Oral Anticoagulant Use in Orthotopic Heart Transplantation Recipients
Over 60 years ago, the vitamin K antagonist (VKA) warfarin was approved and remained the only oral anticoagulation agent until recently [1]. Currently, within North America and Europe there are four DOACs available. Dabigatran, first approved in Europe and Canada in 2008, then in the United States of America in 2010, followed by rivaroxaban, apixaban, and most recently edoxaban. The introduction of direct oral anticoagulants (DOACs) has been a major advancement and these agents are the preferred to VKAs for many indications [2 –5], including stroke prevention in nonvalvular atrial fibrillation (NVAF), acute treatment and...
Source: Transplantation Reviews - April 16, 2018 Category: Transplant Surgery Authors: Rosaleen Boswell, Glen J. Pearson Tags: Review article Source Type: research

Contemporary Approach to Stroke Prevention in Atrial Fibrillation: Risks, Benefits, And New Options
Atrial fibrillation is a common diagnosis affecting nearly 3 million adults in the United States. Morbidity and mortality in these patients is driven largely by the associated increased risk of thromboembolic complications, especially stroke. Atrial fibrillation is a stronger risk factor than hypertension, coronary disease, or heart failure and is associated with an approximately five-fold increased risk. Mitigating stroke risk can be challenging and requires accurate assessment of stroke risk factors and careful selection of appropriate therapy.
Source: Trends in Cardiovascular Medicine - April 4, 2018 Category: Cardiology Authors: Jonathan Stock, Brian J. Malm Source Type: research

Predictors of Oral Anticoagulant Non-prescription in Patients with Atrial Fibrillation and Elevated Stroke Risk
Conclusions In this registry of AF patients, older patients at elevated stroke and low bleeding risk were commonly treated with OAC. However, a variety of factors were associated with OAC non-prescription. Specifically, antiplatelet use was prevalent and associated with the highest likelihood of OAC non-prescription. Future studies are warranted to understand provider and patient rationale that may underlie observed associations with OAC non-prescription.
Source: American Heart Journal - March 11, 2018 Category: Cardiology Source Type: research

Creation and Implementation of an Outpatient Pathway for Atrial Fibrillation in the Emergency Department Setting: Results of an Expert Panel.
This article is protected by copyright. All rights reserved. PMID: 29524340 [PubMed - as supplied by publisher]
Source: Accident and Emergency Nursing - March 10, 2018 Category: Emergency Medicine Authors: Baugh CW, Clark CL, Wilson JW, Stiell IG, Kocheril AG, Luck KK, Myers TD, Pollack CV, Roumpf SK, Tomassoni GF, Williams JM, Patel BB, Wu F, Pines JM Tags: Acad Emerg Med Source Type: research

Long-Term Cognitive Decline After Newly Diagnosed Heart Failure: Longitudinal Analysis in the CHS (Cardiovascular Health Study) Original Articles
Conclusions: Decline in global cognitive ability tends to be faster after HF diagnosis than without HF. Clinical and public health implications of this finding warrant further attention.
Source: Circulation: Heart Failure - March 9, 2018 Category: Cardiology Authors: Hammond, C. A., Blades, N. J., Chaudhry, S. I., Dodson, J. A., Longstreth, W. T., Heckbert, S. R., Psaty, B. M., Arnold, A. M., Dublin, S., Sitlani, C. M., Gardin, J. M., Thielke, S. M., Nanna, M. G., Gottesman, R. F., Newman, A. B., Thacker, E. L. Tags: Clinical Studies, Epidemiology, Heart Failure Original Articles Source Type: research

Creation and Implementation of an Outpatient Pathway for Atrial Fibrillation in the Emergency Department Setting: Results of an Expert Panel
This article is protected by copyright. All rights reserved.
Source: Academic Emergency Medicine - March 1, 2018 Category: Emergency Medicine Authors: Christopher W. Baugh, Carol L. Clark, Jason W. Wilson, Ian G. Stiell, Abraham G. Kocheril, Krista K. Luck, Troy D. Myers, Charles V. Pollack, Steven K. Roumpf, Gery F. Tomassoni, James M. Williams, Brian B. Patel, Fred Wu, Jesse M. Pines Tags: Special Contribution Source Type: research

Temporal trends of in ‐hospital complications associated with catheter ablation of atrial fibrillation in united states: An update from nationwide inpatient sample database (2011‐2014)
ConclusionOur study noted a decline in AF ablation related hospitalizations and complications associated with the procedure. These findings largely reflect shifting trends of outpatient performance of the procedure and increasing safety profile due to improved institutional expertise and catheter techniques.This article is protected by copyright. All rights reserved
Source: Journal of Cardiovascular Electrophysiology - February 1, 2018 Category: Cardiology Authors: Byomesh Tripathi, Shilpkumar Arora, Varun Kumar, Mohamed Abdelrahman, Sopan Lahewala, Mihir Dave, Mahek Shah, Bryan Tan, Sejal Savani, Apurva Badheka, Radha Gopalan, Ghanshyam Palamaner Subash Shantha, Juan Viles Gonzales, Abhishek Deshmukh Tags: ORIGINAL ARTICLE Source Type: research

Stroke prevention strategies in North American patients with atrial fibrillation: the GLORIA ‐AF registry program
ConclusionsIn GLORIA‐AF, 20% of the population comprising males with CHA2DS2‐VASc ≥1 and females with CHA2DS2‐VASc ≥2 did not receive oral anticoagulation therapy. Patient characteristics associated with a lower likelihood of OAC prescription were use of antiplatelet drugs, paroxysmal pattern of AF, a history of falls, and prior bleeding.
Source: Clinical Cardiology - February 1, 2018 Category: Cardiology Authors: William F. McIntyre, David Conen, Brian Olshansky, Jonathan L. Halperin, Emil Hayek, Menno V. Huisman, Gregory Y.H. Lip, Shihai Lu, Jeff S. Healey Tags: CLINICAL INVESTIGATIONS Source Type: research

Left Atrial Appendage Occlusion for Prevention of Thromboembolic Events
More than 600  000 patients in the United States undergo cardiac operations each year, including coronary artery bypass graft operations, valve repair or replacement procedures, or other more complex operations. Patients with atrial fibrillation (AF) who undergo these procedures are at risk for postoperative th romboembolic complications, with the left atrial appendage being a common site of thrombus formation. Occlusion of the left atrial appendage may reduce the risk of thromboembolic stroke and can be performed intraoperatively at the time of cardiac operations. The most common surgical approaches to ac hieve left atr...
Source: JAMA - January 23, 2018 Category: General Medicine Source Type: research